SenerYZCeasovschihA. Letter: the role of medical treatment on outcomes after endovascular revascularization of infrainguinal peripheral artery disease. Angiology. 2025;76(10):1045-1046.
2.
KorosoglouGFeldJLanghoffR, et al. Safety and effectiveness of debulking for the treatment of infrainguinal peripheral artery disease. Data from the recording Courses of vascular diseases registry in 2910 patients. Angiology. 2025;76(10):981-990.
3.
MazzolaiLTeixido-TuraGLanziS, et al.2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 202430:ehae179. DOI: 10.1093/eurheartj/ehae179.
4.
WeichselLGiesenAAndreF, et al.Comparison of two contemporary quantitative atherosclerotic plaque assessment tools for coronary computed tomography angiography: single-center analysis and multi-center patient cohort validation. Diagnostics. 2024;14:154.
5.
WeichselLAndreFRenkerM, et al. Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study. Clin Res Cardiol. 2024. DOI: 10.1007/s00392-024-02502-6.
6.
MessihaDPetrikhovichOLortzJ, et al.Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases. Vasa. 2023;52:379-385.
7.
MessihaDPetrikhovichOLortzJ, et al.Gender differences in outpatient peripheral artery disease management in Germany: a population based study 2009-2018. Eur J Vasc Endovasc Surg. 2022;63:714-720.
8.
RammosCSteinmetzMLortzJ, et al.Peripheral artery disease in Germany (2009-2018): prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy - a population-based study. Lancet Reg Health Eur. 2021;5:100113.
9.
MalyarNStausbergJLanghoffR, et al.Demographic and procedural characteristics in the recording courses of vascular diseases (RECCORD) registry - the first 1000 patients. Vasa. 2020;49:382-388.
10.
StellaJStausbergJLichtenbergMHoffmannUMalyarNMRECCORD Investigators. Clinical characteristics and current practice of endovascular revascularization in aorto-iliac, femoropopliteal and infra-popliteal lower extremity artery disease-insights from the RECCORD registry. J Clin Med. 2022;11:6074.
11.
LichtenbergMKorosoglouG. Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions. J Cardiovasc Surg. 2019;60:205-211.
12.
RammosCManzkeALortzJ, et al.Mechanical atherothrombectomy improves endothelial function through plaque burden reduction in PAD. Vasa. 2022;51:377-385.
13.
GiuscaSHagstotzSLichtenbergM, et al.Phoenix atherectomy for patients with peripheral artery disease. EuroIntervention. 2022;18:e432-e442.
14.
SchofthalerCTroisiNTorselloG, et al.Safety and effectiveness of the Phoenix atherectomy device for endovascular treatment of common femoral and popliteal arteries: results of the EN-MOBILE trial. Vasc Med. 2024;29:405-415.
15.
KronlageMErbelCLichtenbergM, et al.Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions. Vasa. 2021;50:378-386.
16.
GiuscaSLichtenbergMSchuelerM, et al.Publisher Correction to: safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy. Heart Ves. 2022;37:711.
17.
DonasKPPsyllasAPitouliasAG, et al.Periprocedural outcomes of rotational atherectomy-assisted balloon angioplasty in isolated atherosclerotic popliteal artery lesions: the ISO-POP trial. J Clin Med. 2023;12:2797.
18.
BohmeTRomanoLMacharzinaRR, et al.Outcomes of directional atherectomy for common femoral artery disease. EuroIntervention. 2021;17:260-266.
19.
FeldmanDNArmstrongEJAronowHD, et al.SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Cathet Cardiovasc Interv. 2018;92:124-140.
KorosoglouGBlessingEGrozingerGTeichgraberUSchmidtAZellerT. Endovascular therapy or surgery for chronic limb threatening ischemia?Vasa. 2023;52:214-217.
